fluconazole has been researched along with Dermatophytoses in 58 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the use of prophylactic oral fluconazole in reducing the incidence of tinea gladiatorum in high school wrestlers." | 9.14 | Fluconazole as a prophylactic measure for tinea gladiatorum in high school wrestlers. ( Brickman, K; Einstein, E; Guiness, M; Ryno, J; Sinha, S, 2009) |
| "Griseofulvin has been the mainstay of treatment for tinea imbricata (TI) for decades; however, there have been few reports of efficacy of newer antifungals in the treatment of this condition." | 9.11 | Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. ( Fernandez-Obregon, AC; Greer, DL; Wignall, FS; Wingfield, AB, 2004) |
| "We sought to test the efficacy of oral antifungal treatment for Trichophyton-induced asthma by using fluconazole in a placebo-controlled trial." | 9.09 | Treatment of late-onset asthma with fluconazole. ( Hayden, ML; Jackson, S; Platts-Mills, TA; Ward, GW; Woodfolk, JA, 1999) |
| "Fluconazole is effective and safe for primary prevention of tinea gladiatorum." | 9.09 | Fluconazole for the prevention and treatment of tinea gladiatorum. ( Evans, D; Hill, T; Kohl, TD; Martin, DC; Nemeth, R, 2000) |
| "In a double-blind, parallel group study we compared fluconazole 150 mg once weekly with griseofulvin 500 mg once daily for 4-6 weeks in the treatment of tinea corporis or tinea cruris." | 9.08 | A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. ( Faergemann, J; Haglund, A; Mörk, NJ; Odegård, T, 1997) |
| "In an open, noncomparative study, tinea corporis and cruris patients were treated with once weekly fluconazole 150 mg over 2-4 weeks." | 9.08 | Fluconazole in the treatment of tinea corporis and tinea cruris. ( Sarnow, E; Stary, A, 1998) |
| "We treated 20 patients who had tinea corporis and/or tinea cruris and 20 patients who had tinea pedis with oral fluconazole." | 9.07 | Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis. ( Montero-Gei, F; Perera, A, 1992) |
| "The novel triazoles showed potent activity against dermatophytes and promising candidates for the treatment of tinea pedis caused by Trichophyton and Epidermophyton species." | 7.96 | Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis. ( Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M, 2020) |
| "Ninety-five adult out-patients with tinea corporis and/or tinea cruris participated in a multicentre open non-comparative study investigating the safety and efficacy of 1-4 once-weekly doses of oral fluconazole 150 mg." | 7.68 | Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis. ( Gei, FM; Male, O; Perera-Ramírez, A; Robles, M; Suchil, P; Welsh, O, 1992) |
| "We tested the effectiveness of oral fluconazole, griseofulvin, itraconazole and terbinafine in chronic and chronic relapsing tinea corporis, tinea cruris and tinea faciei in an investigator-initiated, randomized, pragmatic trial." | 5.34 | Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial. ( Anchan, VN; Chandra, U; Singh, S; Tilak, R; Verma, P, 2020) |
| "To evaluate the use of prophylactic oral fluconazole in reducing the incidence of tinea gladiatorum in high school wrestlers." | 5.14 | Fluconazole as a prophylactic measure for tinea gladiatorum in high school wrestlers. ( Brickman, K; Einstein, E; Guiness, M; Ryno, J; Sinha, S, 2009) |
| "Griseofulvin has been the mainstay of treatment for tinea imbricata (TI) for decades; however, there have been few reports of efficacy of newer antifungals in the treatment of this condition." | 5.11 | Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. ( Fernandez-Obregon, AC; Greer, DL; Wignall, FS; Wingfield, AB, 2004) |
| "We sought to test the efficacy of oral antifungal treatment for Trichophyton-induced asthma by using fluconazole in a placebo-controlled trial." | 5.09 | Treatment of late-onset asthma with fluconazole. ( Hayden, ML; Jackson, S; Platts-Mills, TA; Ward, GW; Woodfolk, JA, 1999) |
| "Fluconazole is effective and safe for primary prevention of tinea gladiatorum." | 5.09 | Fluconazole for the prevention and treatment of tinea gladiatorum. ( Evans, D; Hill, T; Kohl, TD; Martin, DC; Nemeth, R, 2000) |
| "In a double-blind, parallel group study we compared fluconazole 150 mg once weekly with griseofulvin 500 mg once daily for 4-6 weeks in the treatment of tinea corporis or tinea cruris." | 5.08 | A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. ( Faergemann, J; Haglund, A; Mörk, NJ; Odegård, T, 1997) |
| "In an open, noncomparative study, tinea corporis and cruris patients were treated with once weekly fluconazole 150 mg over 2-4 weeks." | 5.08 | Fluconazole in the treatment of tinea corporis and tinea cruris. ( Sarnow, E; Stary, A, 1998) |
| "We treated 20 patients who had tinea corporis and/or tinea cruris and 20 patients who had tinea pedis with oral fluconazole." | 5.07 | Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis. ( Montero-Gei, F; Perera, A, 1992) |
| " This article gives a review of the effectiveness of the oral antifungal agents fluconazole, itraconazole, and terbinafine in the treatment of pityriasis versicolor, tinea corporis/cruris, and tinea pedis." | 4.80 | Oral therapy of common superficial fungal infections of the skin. ( Lesher, JL, 1999) |
| "The novel triazoles showed potent activity against dermatophytes and promising candidates for the treatment of tinea pedis caused by Trichophyton and Epidermophyton species." | 3.96 | Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis. ( Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M, 2020) |
| "Ninety-five adult out-patients with tinea corporis and/or tinea cruris participated in a multicentre open non-comparative study investigating the safety and efficacy of 1-4 once-weekly doses of oral fluconazole 150 mg." | 3.68 | Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis. ( Gei, FM; Male, O; Perera-Ramírez, A; Robles, M; Suchil, P; Welsh, O, 1992) |
| " Fluconazole in a weekly dosing schedule should be considered in the first-line treatment of tinea gladiatorum." | 2.69 | Comparison of topical and oral treatments for tinea gladiatorum. ( Berger, MS; Kohl, TD; Martin, DC, 1999) |
| "To detected N." | 1.72 | Nannizzia incurvata in Hue city - Viet Nam: Molecular identification and antifungal susceptibility testing. ( Do, TBT; Ha, TNT; Le, CC; Ngo, TMC; Nguyen, PV; Santona, A; Ton Nu, PA; Tran Thi, G; Vo, MT, 2022) |
| "Ellagic acid (EA) has been shown to have antioxidant, antibacterial, and anti-inflammatory activities." | 1.42 | Antifungal Activity of Ellagic Acid In Vitro and In Vivo. ( Aibai, S; Dawuti, G; Guo, X; Li, ZJ, 2015) |
| "Voriconazole was the most and fluconazole was the less-active drug." | 1.34 | Antifungal susceptibility testing of Trichophyton rubrum by E-test. ( da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J, 2007) |
| "Treatment with Fluconazole for a period of four weeks successfully cured the infection." | 1.34 | Exacerbated inflammatory reaction to Trichophyton rubrum infection on an HIV-positive patient successfully treated with fluconazole. ( de Oliveira Teixeira, F; Mendoza, L; Vilela, L; Vilela, R, 2007) |
| "After Trichophyton mentagrophytes infections had been established in the test animals, the antifungal agents were administered once per day for 14 days." | 1.31 | Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis. ( Nagino, K; Ogawa, M; Shimohira, H; Uchida, K; Yamaguchi, H, 2000) |
| "Fluconazole was about four times less effective than SM-8668 against systemic candidiasis and was only slightly effective at doses of 80 and 25 mg/kg against systemic aspergilosis and cryptococcosis, respectively." | 1.28 | In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent. ( Ichise, K; Nakajima, T; Okuda, T; Tanio, T, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.72) | 18.7374 |
| 1990's | 20 (34.48) | 18.2507 |
| 2000's | 18 (31.03) | 29.6817 |
| 2010's | 15 (25.86) | 24.3611 |
| 2020's | 4 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Onyewu, C | 1 |
| Eads, E | 1 |
| Schell, WA | 1 |
| Perfect, JR | 1 |
| Ullmann, Y | 1 |
| Kaufman, G | 1 |
| Horwitz, BA | 1 |
| Berdicevsky, I | 1 |
| Heitman, J | 1 |
| Ngo, TMC | 1 |
| Ton Nu, PA | 1 |
| Le, CC | 1 |
| Vo, MT | 1 |
| Ha, TNT | 1 |
| Do, TBT | 1 |
| Nguyen, PV | 1 |
| Tran Thi, G | 1 |
| Santona, A | 1 |
| Salehi, Z | 1 |
| Fatahi, N | 1 |
| Taran, M | 1 |
| Izadi, A | 1 |
| Badali, H | 2 |
| Hashemi, SJ | 1 |
| Rezaie, S | 1 |
| Daie Ghazvini, R | 1 |
| Ghaffari, M | 1 |
| Aala, F | 1 |
| Barac, A | 1 |
| Khodavaisy, S | 1 |
| Singh, S | 1 |
| Chandra, U | 1 |
| Anchan, VN | 1 |
| Verma, P | 1 |
| Tilak, R | 1 |
| Elewski, B | 1 |
| Dev, T | 1 |
| Saginatham, H | 1 |
| Sethuraman, G | 1 |
| Czaika, VA | 1 |
| Lam, PA | 1 |
| Hryncewicz-Gwóźdź, A | 1 |
| Kalinowska, K | 1 |
| Plomer-Niezgoda, E | 1 |
| Bielecki, J | 1 |
| Jagielski, T | 1 |
| Segal, D | 1 |
| Wells, MM | 1 |
| Rahalkar, A | 1 |
| Joseph, M | 1 |
| Mrkobrada, M | 1 |
| Lourdes, LS | 1 |
| Mitchell, CL | 1 |
| Glavin, FL | 1 |
| Schain, DC | 1 |
| Kaye, FJ | 1 |
| Mohammadi, R | 1 |
| Mashedi, O | 1 |
| de Hoog, GS | 1 |
| Meis, JF | 1 |
| Li, ZJ | 1 |
| Guo, X | 1 |
| Dawuti, G | 1 |
| Aibai, S | 1 |
| Buruiana, AM | 1 |
| Mihali, CV | 1 |
| Popescu, C | 1 |
| de Oliveira Lima, MI | 1 |
| Araújo de Medeiros, AC | 1 |
| Souza Silva, KV | 1 |
| Cardoso, GN | 1 |
| de Oliveira Lima, E | 1 |
| de Oliveira Pereira, F | 1 |
| Bafumi, TR | 1 |
| Carroll, VG | 1 |
| Gohel, MC | 1 |
| Nagori, SA | 1 |
| Brickman, K | 1 |
| Einstein, E | 1 |
| Sinha, S | 1 |
| Ryno, J | 1 |
| Guiness, M | 1 |
| Neji, S | 1 |
| Makni, F | 1 |
| Cheikhrouhou, F | 1 |
| Sellami, H | 1 |
| Boudaya, S | 1 |
| Turki, H | 1 |
| Ayadi, A | 1 |
| Khan, MS | 1 |
| Ahmad, I | 1 |
| Feily, A | 1 |
| Namazi, MR | 1 |
| Seifmanesh, H | 1 |
| Gönül, M | 1 |
| Saraçlı, MA | 1 |
| Demiriz, M | 1 |
| Gül, U | 1 |
| Tchernev, G | 1 |
| Penev, PK | 1 |
| Nenoff, P | 1 |
| Zisova, LG | 1 |
| Cardoso, JC | 1 |
| Taneva, T | 1 |
| Ginter-Hanselmayer, G | 1 |
| Ananiev, J | 1 |
| Gulubova, M | 1 |
| Hristova, R | 1 |
| Nocheva, D | 1 |
| Guarneri, C | 1 |
| Martino, G | 1 |
| Kanazawa, N | 1 |
| Machan, M | 1 |
| Kestenbaum, T | 1 |
| Fraga, GR | 1 |
| Shenoy, R | 1 |
| Shenoy, UA | 1 |
| al Mahrooqui, ZH | 1 |
| Wingfield, AB | 1 |
| Fernandez-Obregon, AC | 1 |
| Wignall, FS | 1 |
| Greer, DL | 1 |
| Negroni, R | 1 |
| Tuculet, MA | 1 |
| Ledezma, E | 1 |
| Apitz-Castro, R | 1 |
| Tietz, HJ | 1 |
| da Silva Barros, ME | 1 |
| de Assis Santos, D | 1 |
| Soares Hamdan, J | 1 |
| Vilela, R | 1 |
| de Oliveira Teixeira, F | 1 |
| Vilela, L | 1 |
| Mendoza, L | 1 |
| Méndez-Tovar, LJ | 1 |
| Manzano-Gayosso, P | 1 |
| Velásquez-Hernández, V | 1 |
| Millan-Chiu, B | 1 |
| Hernández-Hernández, F | 1 |
| Mondragón-González, R | 1 |
| López-Martínez, R | 1 |
| Balci, DD | 1 |
| Cetin, M | 1 |
| Halasz, CL | 1 |
| Mieth, H | 1 |
| Leitner, I | 1 |
| Meingassner, JG | 1 |
| Stengel, F | 1 |
| Robles-Soto, M | 1 |
| Galimberti, R | 1 |
| Suchil, P | 2 |
| Lospalluti, M | 1 |
| Barile, F | 1 |
| Pantaleo, AK | 1 |
| Conese, M | 1 |
| Guerra, AP | 1 |
| Lo Re, M | 1 |
| D'Amico, G | 1 |
| Barbieri, G | 1 |
| Parmegiani, RM | 1 |
| Loebenberg, D | 1 |
| Cacciapuoti, A | 1 |
| Antonacci, B | 1 |
| Norris, C | 1 |
| Menzel, F | 1 |
| Moss, L | 1 |
| Yarosh-Tomaine, T | 1 |
| Hare, RS | 1 |
| Miller, GH | 1 |
| Faergemann, J | 1 |
| Mörk, NJ | 1 |
| Haglund, A | 1 |
| Odegård, T | 1 |
| Kapdağli, H | 1 |
| Oztürk, G | 1 |
| Dereli, T | 1 |
| Inci, R | 1 |
| Hilmioğlu, Z | 1 |
| Kazandi, AC | 1 |
| Erboz, S | 1 |
| Hernanz Hermosa, JM | 1 |
| Lázaro Ochaita, P | 1 |
| Stary, A | 1 |
| Sarnow, E | 1 |
| Nozickova, M | 1 |
| Koudelkova, V | 1 |
| Kulikova, Z | 1 |
| Malina, L | 1 |
| Urbanowski, S | 1 |
| Silny, W | 1 |
| Howard, RM | 1 |
| Frieden, IJ | 1 |
| Böhmer, U | 1 |
| Korting, HC | 2 |
| Lesher, JL | 1 |
| Stempel, DA | 1 |
| Ward, GW | 1 |
| Woodfolk, JA | 1 |
| Hayden, ML | 1 |
| Jackson, S | 1 |
| Platts-Mills, TA | 1 |
| Kohl, TD | 2 |
| Martin, DC | 2 |
| Berger, MS | 1 |
| Niewerth, M | 1 |
| Nagino, K | 2 |
| Shimohira, H | 2 |
| Ogawa, M | 2 |
| Uchida, K | 2 |
| Yamaguchi, H | 2 |
| Nemeth, R | 1 |
| Hill, T | 1 |
| Evans, D | 1 |
| Smith, KJ | 1 |
| Welsh, M | 1 |
| Skelton, H | 1 |
| Gei, FM | 1 |
| Robles, M | 1 |
| Perera-Ramírez, A | 1 |
| Welsh, O | 1 |
| Male, O | 1 |
| Montero-Gei, F | 1 |
| Perera, A | 1 |
| Gatti, S | 1 |
| Marinaro, C | 1 |
| Bianchi, L | 1 |
| Nini, G | 1 |
| Tanio, T | 1 |
| Ichise, K | 1 |
| Nakajima, T | 1 |
| Okuda, T | 1 |
| Richardson, K | 1 |
| Brammer, KW | 1 |
| Marriott, MS | 1 |
| Troke, PF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata in an Indigenous Tribe in Southern Philippines :a Pilot Study[NCT03745183] | 20 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for fluconazole and Dermatophytoses
| Article | Year |
|---|---|
Onychomycosis: modern diagnostic and treatment approaches.
Topics: Antifungal Agents; Candidiasis; Combined Modality Therapy; Dermatomycoses; DNA, Fungal; Enzyme-Linke | 2013 |
[Ajoene the main active compound of garlic (Allium sativum): a new antifungal agent].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Clinical Trials as Topic; Derma | 2006 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Chil | 1995 |
Dermatophyte infections in children.
Topics: Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Fluconazole; Griseofulvin; Humans; It | 1999 |
Oral therapy of common superficial fungal infections of the skin.
Topics: Administration, Oral; Antifungal Agents; Drug Administration Schedule; Fluconazole; Humans; Itracona | 1999 |
12 trials available for fluconazole and Dermatophytoses
| Article | Year |
|---|---|
Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Naphthalenes; | 2020 |
Fluconazole as a prophylactic measure for tinea gladiatorum in high school wrestlers.
Topics: Adolescent; Antifungal Agents; Fluconazole; Humans; Longitudinal Studies; Prospective Studies; Tinea | 2009 |
Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Fluconazole; Griseofulvin; Humans; Itraco | 2004 |
Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis.
Topics: Adult; Candida; Candidiasis, Cutaneous; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; | 1994 |
[Comparative evaluation of fluconazole 50 mg and 100 mg versus itraconazole 100 mg in the treatment of dermatomycoses].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Double-Blind Method; Female; Fluconazole; Follow- | 1994 |
A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Drug Administrat | 1997 |
Fluconazole in the treatment of tinea corporis and tinea cruris.
Topics: Antifungal Agents; Dermatomycoses; Dose-Response Relationship, Drug; Drug Evaluation; Female; Flucon | 1998 |
A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candida; Candidiasis; Chemical and Drug Induced Live | 1998 |
Treatment of late-onset asthma with fluconazole.
Topics: Adult; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antifungal Agents; Asthma; Double-Blin | 1999 |
Comparison of topical and oral treatments for tinea gladiatorum.
Topics: Administration, Oral; Administration, Topical; Adolescent; Antifungal Agents; Clotrimazole; Drug Adm | 1999 |
Fluconazole for the prevention and treatment of tinea gladiatorum.
Topics: Adolescent; Antifungal Agents; Double-Blind Method; Fluconazole; Humans; Incidence; Male; Primary Pr | 2000 |
Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis.
Topics: Administration, Oral; Adult; Drug Tolerance; Female; Fluconazole; Follow-Up Studies; Humans; Male; M | 1992 |
41 other studies available for fluconazole and Dermatophytoses
| Article | Year |
|---|---|
Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model.
Topics: Antifungal Agents; Calcineurin; Colony Count, Microbial; Culture Media; Cyclosporine; Drug Synergism | 2007 |
Nannizzia incurvata in Hue city - Viet Nam: Molecular identification and antifungal susceptibility testing.
Topics: Antifungal Agents; Arthrodermataceae; DNA, Ribosomal; Drug Resistance, Fungal; Fluconazole; Humans; | 2022 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; | 2020 |
A call for antifungal stewardship.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Pharmaceutical | 2020 |
Tinea Faciei: Challenges in the Diagnosis.
Topics: Administration, Oral; Antifungal Agents; Child, Preschool; Facial Dermatoses; Fluconazole; Griseoful | 2017 |
Trichophyton mentagrophytes cause underestimated contagious zoophilic fungal infection.
Topics: Administration, Oral; Administration, Topical; Adult; Animals; Anti-Inflammatory Agents; Antifungal | 2013 |
Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.
Topics: Antifungal Agents; Culture Media; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microb | 2013 |
A case of tinea incognito.
Topics: Antifungal Agents; Biopsy; Calcitriol; Combined Modality Therapy; Diagnostic Errors; Exanthema; Fluc | 2013 |
Recurrent dermatophytosis (Majocchi granuloma) associated with chemotherapy-induced neutropenia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Flucon | 2014 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Flucon | 2015 |
Antifungal Activity of Ellagic Acid In Vitro and In Vivo.
Topics: Administration, Cutaneous; Animals; Antifungal Agents; Arthrodermataceae; Candida; Disease Models, A | 2015 |
Sequence-Based Identification of a Zoophilic Strain of Trichophyton interdigitale in a Rare Case of Tinea Blepharo-Ciliaris Associated with Tinea Barbae.
Topics: Administration, Oral; Antifungal Agents; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Facia | 2015 |
Investigation of the antifungal potential of linalool against clinical isolates of fluconazole resistant Trichophyton rubrum.
Topics: Acyclic Monoterpenes; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Ketoconazole; | 2017 |
Skin lesions in a neonate.
Topics: Administration, Oral; Drug Therapy, Combination; Facial Dermatoses; Fluconazole; Follow-Up Studies; | 2009 |
Fabrication and design of transdermal fluconazole spray.
Topics: Administration, Cutaneous; Adult; Animals; Antifungal Agents; Camphor; Candida albicans; Cellulose; | 2009 |
First case of Trichophyton soudanense isolated in Tunisia.
Topics: Adult; Antifungal Agents; Ciclopirox; Cote d'Ivoire; Econazole; Fluconazole; Humans; Male; Nails; Py | 2010 |
Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Fluconazole; Gas C | 2011 |
Generalized pustular psoriasis-like dermatophytosis due to Trichophyton rubrum.
Topics: Antifungal Agents; Diagnosis, Differential; Female; Fluconazole; Humans; Middle Aged; Psoriasis; Tin | 2011 |
Deep Trichophyton rubrum infection presenting with umbilicated papulonodules in a cardiac transplant recipient.
Topics: Cytoplasm; Dermatomycoses; Fluconazole; Giant Cells; Heart Transplantation; Humans; Hyphae; Male; Mi | 2013 |
Diffuse hyperkeratosis in a deaf and blind 48-year-old woman--quiz case. Diagnosis: keratitis-ichthyosis-deafness (KID) syndrome with secondary dermatophytosis.
Topics: Antifungal Agents; Baths; Blindness; Deafness; Dermatologic Agents; Female; Fluconazole; Humans; Ich | 2012 |
Keratomycosis due to Trichophyton mentagrophytes.
Topics: Antifungal Agents; Corneal Ulcer; Female; Fluconazole; Humans; Middle Aged; Tinea; Trichophyton | 2003 |
[Clinical cases in medical mycology. Case No. 16].
Topics: Adolescent; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Blood Sedimen | 2005 |
[Current treatment recommendations in tinea corporis?].
Topics: Antifungal Agents; Clotrimazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terb | 2006 |
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Keto | 2007 |
Exacerbated inflammatory reaction to Trichophyton rubrum infection on an HIV-positive patient successfully treated with fluconazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Fluconazole; HIV Infections | 2007 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Funga | 2007 |
Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Female; Fluconazole; Humans; Imidazoles; Itraco | 2008 |
Successful treatment with fluconazole of tinea corporis caused by Trichophyton verrucosum (barn ich).
Topics: Administration, Oral; Adult; Female; Fluconazole; Humans; Tinea; Trichophyton | 1994 |
The efficacy of orally applied terbinafine, itraconazole and fluconazole in models of experimental trichophytoses.
Topics: Administration, Oral; Animals; Antifungal Agents; Disease Models, Animal; Female; Fluconazole; Guine | 1994 |
Sch 39304, a new antifungal agent: oral and topical treatment of vaginal and superficial infections.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Candidiasis, Vulvovaginal | 1993 |
Candida folliculitis mimicking tinea barbae.
Topics: Antifungal Agents; Candidiasis, Cutaneous; Diagnosis, Differential; Fluconazole; Folliculitis; Human | 1997 |
[Trichophyton rubrum syndrome with axillary tinea infection].
Topics: Antifungal Agents; Axilla; Dermatomycoses; Fluconazole; Humans; Male; Middle Aged; Tinea; Trichophyt | 1999 |
New understanding of disease mechanisms: excitement and caution.
Topics: Adrenal Cortex Hormones; Anti-Asthmatic Agents; Antifungal Agents; Asthma; Clinical Trials as Topic; | 1999 |
The use of systemic antimycotics in dermatotherapy.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomy | 2000 |
Comparison of the therapeutic efficacy of oral doses of fluconazole and griseofulvin in a guinea pig model of dermatophytosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Dermatomycoses; Disease Models, Animal; Female; Fl | 2000 |
Trichophyton rubrum showing deep dermal invasion directly from the epidermis in immunosuppressed patients.
Topics: Adolescent; Adult; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Combi | 2001 |
Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Dermatomycoses; Disease Models, Animal; Female; Fl | 2000 |
Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis, Cutaneous; Drug Administration Schedule; Femal | 1992 |
Treatment of kerion with fluconazole.
Topics: Adult; Fluconazole; Humans; Male; Scalp Dermatoses; Tinea; Trichophyton | 1991 |
In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergil | 1990 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; | 1985 |